Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
27.85
-0.05
(-0.18%)
At close: February 28 at 4:42:48 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
Investing Cash Flow
-553,366
-553,366
-179,086
54,753
37,960
Financing Cash Flow
612,464
612,464
271,376
4,163
6,880
End Cash Position
26,676
26,676
55,516
36,632
26,371
Issuance of Capital Stock
597,094
597,094
269,760
--
--
Repurchase of Capital Stock
--
--
--
-6,817
--
Free Cash Flow
-87,790
-87,790
-73,376
-48,397
-47,586
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
W2J.F Carisma Therapeutics, Inc.
0.3784
-4.01%
S09.BE Sutro Biopharma Inc
1.4700
-2.65%
W2J.SG CARISMA Therapeutics Inc
0.3846
-0.41%
S09.MU Sutro Biopharma Inc
1.5200
-3.18%
0M4.BE Mersana Therapeutics Inc
0.4744
-0.94%
S09.F Sutro Biopharma, Inc.
1.4700
-2.00%
0M4.F Mersana Therapeutics, Inc.
0.4243
-1.94%
0M4.MU Mersana Therapeutics Inc
0.4915
-5.15%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.06
+1.58%
BLRX.TA BioLineRx Ltd.
2.0000
-4.76%